Experimental drug shows promise for lewy body dementia
NCT ID NCT06815965
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 21 times
Summary
This study tested an experimental drug called neflamapimod in 26 people with dementia with Lewy bodies (DLB). The main goal was to check if the drug is safe and how it behaves in the body. Researchers also looked at whether it might help with thinking and memory, but this was a small, early-stage study, not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA WITH LEWY BODIES (DLB) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Lariboisière - APHP; Centre de Neurologie Cognitive
Paris, 75010, France
-
Strasbourg University Hospital (Les Hopitaux Universitaires de Strasbourg)
Strasbourg, 67000, France
Conditions
Explore the condition pages connected to this study.